# Algorhythm Holdings, Inc.: financial statements, quarterly

RIME · Nasdaq · CIK 923601 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rime.md) · [Financials](/companies/rime/financials.md) · [Filings](/companies/rime/filings.md) · [Insiders](/companies/rime/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rime/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [15.9](/filings/0001493152-24-046807.md) | [10.6 d](/filings/0001641172-25-004792.md) | [2.4](/filings/0001641172-25-010876.md) | [2.4](/filings/0001641172-25-024828.md) | [0.1](/filings/0001493152-25-024305.md) | [0.2 d](/filings/0001493152-26-014724.md) | [0.1](/filings/0001493152-26-022876.md) | [1.2](/filings/0001493152-26-038024.md) | [1.7](/filings/0001493152-25-024305.md) | [1.4 d](/filings/0001493152-26-014724.md) | [2.4](/filings/0001493152-26-022876.md) | [3.0](/filings/0001493152-26-038024.md) |
| Cost of revenue | $m | [12.2](/filings/0001493152-24-046807.md) | [9.0 d](/filings/0001641172-25-004792.md) | [1.9](/filings/0001641172-25-010876.md) | [2.1](/filings/0001641172-25-024828.md) | [0.2](/filings/0001493152-25-024305.md) | [0.3 d](/filings/0001493152-26-014724.md) | [0.1](/filings/0001493152-26-022876.md) | [1.5](/filings/0001493152-26-038024.md) | [2.1](/filings/0001493152-25-024305.md) | [2.0 d](/filings/0001493152-26-014724.md) | [3.1](/filings/0001493152-26-022876.md) | [3.6](/filings/0001493152-26-038024.md) |
| Gross profit | $m | [3.7](/filings/0001493152-24-046807.md) | [1.6 d](/filings/0001641172-25-004792.md) | [0.5](/filings/0001641172-25-010876.md) | [0.3](/filings/0001641172-25-024828.md) | [(0.0)](/filings/0001493152-25-024305.md) | [(0.2) d](/filings/0001493152-26-014724.md) | [(0.0)](/filings/0001493152-26-022876.md) | [(0.3)](/filings/0001493152-26-038024.md) | [(0.4)](/filings/0001493152-25-024305.md) | [(0.6) d](/filings/0001493152-26-014724.md) | [(0.7)](/filings/0001493152-26-022876.md) | [(0.6)](/filings/0001493152-26-038024.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [0.1](/filings/0001493152-24-046807.md) | [(3.8) d](/filings/0001641172-25-004792.md) | [(2.3)](/filings/0001641172-25-010876.md) | [(6.2)](/filings/0001641172-25-024828.md) | [(1.8)](/filings/0001493152-25-024305.md) | [(5.6) d](/filings/0001493152-26-014724.md) | [(1.1)](/filings/0001493152-26-022876.md) | [(1.2)](/filings/0001493152-26-038024.md) | [(1.6)](/filings/0001493152-25-024305.md) | [(4.1) d](/filings/0001493152-26-014724.md) | [(4.3)](/filings/0001493152-26-022876.md) | [(2.7)](/filings/0001493152-26-038024.md) |
| Interest expense | $m | [0.1](/filings/0001493152-23-042149.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001493152-25-024305.md) | not reported | not reported | not reported |
| Income tax | $m | [0.0 d](/filings/0001493152-24-046807.md) | not reported | [0.1](/filings/0001641172-25-010876.md) | [(0.1)](/filings/0001641172-25-024828.md) | not reported | not reported | not reported | not reported | [0.0](/filings/0001493152-25-024305.md) | [0.0 d](/filings/0001493152-26-014724.md) | not reported | [0.0](/filings/0001493152-26-038024.md) |
| Net income | $m | [0.1](/filings/0001493152-23-042149.md) | [(4.0) d](/filings/0001493152-24-014674.md) | [(2.4)](/filings/0001493152-24-020033.md) | [(6.1)](/filings/0001493152-24-032956.md) | [1.2](/filings/0001493152-25-024305.md) | [(16.0) d](/filings/0001493152-26-014724.md) | [(9.2)](/filings/0001493152-26-022876.md) | [(0.6)](/filings/0001493152-26-038024.md) | [(3.0)](/filings/0001493152-25-024305.md) | [(3.1) d](/filings/0001493152-26-014724.md) | [(5.1)](/filings/0001493152-26-022876.md) | [(3.8)](/filings/0001493152-26-038024.md) |
| Diluted EPS | $ per share | [0.03](/filings/0001493152-24-046807.md) | not reported | [(73.76)](/filings/0001641172-25-010876.md) | [(190.68)](/filings/0001641172-25-024828.md) | [0.13](/filings/0001493152-25-024305.md) | not reported | [(4.66)](/filings/0001493152-26-022876.md) | [(0.24)](/filings/0001493152-26-038024.md) | [(1.15)](/filings/0001493152-25-024305.md) | not reported | [(0.52)](/filings/0001493152-26-022876.md) | [(0.25)](/filings/0001493152-26-038024.md) |
| Basic EPS | $ per share | [0.03](/filings/0001493152-24-046807.md) | not reported | [(73.76)](/filings/0001641172-25-010876.md) | [(190.68)](/filings/0001641172-25-024828.md) | [0.13](/filings/0001493152-25-024305.md) | not reported | [(4.66)](/filings/0001493152-26-022876.md) | [(0.24)](/filings/0001493152-26-038024.md) | [(1.15)](/filings/0001493152-25-024305.md) | not reported | [(0.52)](/filings/0001493152-26-022876.md) | [(0.25)](/filings/0001493152-26-038024.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | FY2024 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.2](/filings/0001493152-23-042149.md) | [6.7](/filings/0001493152-24-014674.md) | [4.1](/filings/0001493152-24-020033.md) | [1.2](/filings/0001493152-24-032956.md) | [0.6](/filings/0001493152-24-046807.md) | [7.2](/filings/0001493152-26-014724.md) | [3.3](/filings/0001641172-25-010876.md) | [1.1](/filings/0001641172-25-024828.md) | [2.8](/filings/0001493152-25-024305.md) | [1.6](/filings/0001493152-26-038024.md) | [7.7](/filings/0001493152-26-022876.md) | [5.0](/filings/0001493152-26-038024.md) |
| Current assets | $m | [27.8](/filings/0001493152-23-042149.md) | [23.2](/filings/0001641172-25-004792.md) | [15.5](/filings/0001493152-24-020033.md) | [11.8](/filings/0001493152-24-032956.md) | [14.4](/filings/0001493152-24-046807.md) | [16.8](/filings/0001493152-26-014724.md) | [9.0](/filings/0001641172-25-010876.md) | [7.6](/filings/0001641172-25-024828.md) | [5.5](/filings/0001493152-25-024305.md) | [7.9](/filings/0001493152-26-038024.md) | [13.6](/filings/0001493152-26-022876.md) | [13.4](/filings/0001493152-26-038024.md) |
| Total assets | $m | [32.6](/filings/0001493152-23-042149.md) | [27.7](/filings/0001641172-25-004792.md) | [19.9](/filings/0001493152-24-020033.md) | [12.4](/filings/0001493152-24-032956.md) | [19.6](/filings/0001493152-24-046807.md) | [18.3](/filings/0001493152-26-014724.md) | [10.5](/filings/0001641172-25-010876.md) | [12.7](/filings/0001641172-25-024828.md) | [10.8](/filings/0001493152-25-024305.md) | [12.7](/filings/0001493152-26-038024.md) | [18.5](/filings/0001493152-26-022876.md) | [18.6](/filings/0001493152-26-038024.md) |
| Current liabilities | $m | [19.1](/filings/0001493152-23-042149.md) | [16.2](/filings/0001641172-25-004792.md) | [10.6](/filings/0001493152-24-020033.md) | [9.1](/filings/0001493152-24-032956.md) | [16.5](/filings/0001493152-24-046807.md) | [28.4](/filings/0001493152-26-014724.md) | [6.7](/filings/0001641172-25-010876.md) | [9.3](/filings/0001641172-25-024828.md) | [10.5](/filings/0001493152-25-024305.md) | [14.4](/filings/0001493152-26-038024.md) | [15.2](/filings/0001493152-26-022876.md) | [14.9](/filings/0001493152-26-038024.md) |
| Total liabilities | $m | [22.9](/filings/0001493152-23-042149.md) | [20.1](/filings/0001641172-25-004792.md) | [14.7](/filings/0001493152-24-020033.md) | [13.2](/filings/0001493152-24-032956.md) | [16.9](/filings/0001493152-24-046807.md) | [28.8](/filings/0001493152-26-014724.md) | [7.1](/filings/0001641172-25-010876.md) | [9.9](/filings/0001641172-25-024828.md) | [10.7](/filings/0001493152-25-024305.md) | [14.6](/filings/0001493152-26-038024.md) | [15.3](/filings/0001493152-26-022876.md) | [15.3](/filings/0001493152-26-038024.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | [0.3](/filings/0001493152-24-046807.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [9.7](/filings/0001493152-23-042149.md) | [7.6](/filings/0001493152-24-032956.md) | [5.2](/filings/0001493152-24-032956.md) | [(0.9)](/filings/0001493152-24-032956.md) | [2.7](/filings/0001493152-24-046807.md) | [(10.5)](/filings/0001493152-26-038024.md) | [3.3](/filings/0001493152-26-038024.md) | [2.8](/filings/0001493152-26-038024.md) | [0.1](/filings/0001493152-25-024305.md) | [(1.9)](/filings/0001493152-26-038024.md) | [3.2](/filings/0001493152-26-038024.md) | [3.3](/filings/0001493152-26-038024.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,374 d](/filings/0001493152-24-046807.md) | [1,585 d](/filings/0001641172-25-004792.md) | [(2,557)](/filings/0001641172-25-010876.md) | [(2,853) d](/filings/0001641172-25-024828.md) | [(1,659) d](/filings/0001493152-24-046807.md) | [(1,487) d](/filings/0001641172-25-004792.md) | [(3,108)](/filings/0001641172-25-010876.md) | [(2,328) d](/filings/0001641172-25-024828.md) | [1,093 d](/filings/0001493152-25-024305.md) | [(2,966) d](/filings/0001493152-26-014724.md) | [(3,922)](/filings/0001493152-26-022876.md) | [(2,670) d](/filings/0001493152-26-038024.md) |
| Capital expenditure | $k | [26.0 d](/filings/0001493152-24-046807.md) | [0.0 d](/filings/0001641172-25-004792.md) | not reported | not reported | [64.0 d](/filings/0001493152-24-046807.md) | [0.0 d](/filings/0001641172-25-004792.md) | not reported | not reported | [3.0 d](/filings/0001493152-25-024305.md) | [4.0 d](/filings/0001493152-26-014724.md) | [14.0](/filings/0001493152-26-022876.md) | [5.0 d](/filings/0001493152-26-038024.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities, us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2023 (2022-12-31) | Q4 FY2023 (2023-03-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [3.1](/filings/0001493152-23-005556.md) | [3.1](/filings/0001493152-24-020033.md) | [3.9](/filings/0001493152-24-032956.md) | [4.2](/filings/0001493152-24-046807.md) | [0.0](/filings/0001641172-25-010876.md) | [0.0](/filings/0001641172-25-024828.md) | [9.1](/filings/0001493152-25-024305.md) | [2.0](/filings/0001493152-26-022876.md) | [2.5](/filings/0001493152-26-038024.md) | [2.6](/filings/0001493152-25-024305.md) | [9.9](/filings/0001493152-26-022876.md) | [15.1](/filings/0001493152-26-038024.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,990,135 at 2026-08-11, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038024.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.